Home › Chronic Myeloid Leukemia › Florida › St. Petersburg
Chronic Myeloid Leukemia clinical trials in St. Petersburg, FL
3 studies for Chronic Myeloid Leukemia are looking for participants at sites in and around St. Petersburg (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Saint Anthony's Hospital Cancer Care Center, St. Petersburg
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecruitingObservational study
- All Children's Hospital, St. Petersburg
A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
RecruitingPhase 1/2
- Florida Cancer Specialists - North Region Research Office, St. Petersburg
About Chronic Myeloid Leukemia
Chronic myeloid leukemia (CML) is a cancer of the white blood cells. It usually affects older adults. Learn about symptoms, genetics, and treatment.
More about Chronic Myeloid Leukemia on MedlinePlus
Chronic Myeloid Leukemia trials in other cities
- Houston, TX18 studies
- New York City, NY11 studies
- Seattle, WA11 studies
- Birmingham, AL6 studies
- Philadelphia, PA6 studies
- Portland, OR6 studies
- Detroit, MI6 studies
- Baldwin Park, CA6 studies
- Chicago, IL6 studies
- Durham, NC5 studies
- Nashville, TN5 studies
- Boston, MA5 studies
Other studies in St. Petersburg
- Non-Small Cell Lung Cancer21 studies
- Breast Cancer11 studies
- Obesity9 studies
- Overweight9 studies
- Colorectal Cancer8 studies
- Heart Failure8 studies
- Lung Cancer7 studies
- Endometrial Cancer6 studies
- Burkitt Lymphoma6 studies
- Ovarian Cancer6 studies
- Type 2 Diabetes5 studies
- COPD5 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.